FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1567347505> ?p ?o ?g. }

• W1567347505 endingPage "889" @default.
• W1567347505 startingPage "889" @default.
• W1567347505 abstract "<h3>Importance</h3> Congenital myasthenic syndromes (CMS) are heterogeneous disorders. Defining the phenotypic features, genetic basis, and pathomechanisms of a CMS is relevant to prognosis, genetic counseling, and therapy. <h3>Objectives</h3> To characterize clinical, structural, electrophysiologic, and genetic features of a CMS and to search for optimal therapy. <h3>Design, Settings, and Participants</h3> Two sisters with CMS affecting the limb-girdle muscles were investigated between 2012 and 2014 at an academic medical center by clinical observation, in vitro analysis of neuromuscular transmission, cytochemical and electron microscopy studies of the neuromuscular junction, exome sequencing, expression studies in HEK293 and COS7 cells, and for response to therapy, and they were compared with 15 historical control participants. <h3>Main Outcomes and Measures</h3> We identified the disease gene and mutation, confirmed pathogenicity of the mutation by expression studies, and instituted optimal pharmacotherapy. <h3>Results</h3> Quantitative analysis of single EP regions was done for all 15 control participants and microelectrode studies of neuromuscular transmission and α-bgt binding sites per EP was conducted for 13 control participants. Examination of the older sister’s intercostal muscle end plates (EPs) showed them to be abnormally small, with attenuated reactivities for the acetylcholine receptor and acetylcholinesterase. Most EPs had poorly differentiated or degenerate junctional folds, and some appeared denuded of nerve terminals. The amplitude of the EP potential (EPP), the miniature EPP, and the quantal content of the EPP were all markedly reduced. Exome sequencing identified a novel homozygous p.Glu1233Ala mutation in low-density lipoprotein receptor–related protein 4 (LRP4), a coreceptor for agrin to activate muscle-specific tyrosine kinase (MuSK), which is required for EP development and maintenance. Expression studies indicate that the mutation compromises the ability of LRP4 to bind to, phosphorylate, and activate MuSK. Treatment with albuterol sulfate improved the patients’ symptoms. A previously identified patient harboring 2 heterozygous mutations in LRP4 had structurally abnormal intercostal EPs but no identifiable defect of neuromuscular transmission at these EPs. <h3>Conclusions and Relevance</h3> We identified a second CMS kinship harboring mutations in<i>LRP4</i>, identified the mechanisms that impair neuromuscular transmission, and mitigated the disease by appropriate therapy." @default.
• W1567347505 created "2016-06-24" @default.
• W1567347505 creator A5012431384 @default.
• W1567347505 creator A5017751776 @default.
• W1567347505 creator A5020189594 @default.
• W1567347505 creator A5022478677 @default.
• W1567347505 creator A5052886370 @default.
• W1567347505 creator A5066335738 @default.
• W1567347505 date "2015-08-01" @default.
• W1567347505 modified "2023-09-29" @default.
• W1567347505 title "Impaired Synaptic Development, Maintenance, and Neuromuscular Transmission in LRP4-Related Myasthenia" @default.
• W1567347505 cites W1970866315 @default.
• W1567347505 cites W1983468718 @default.
• W1567347505 cites W1984522719 @default.
• W1567347505 cites W1984665850 @default.
• W1567347505 cites W1991623532 @default.
• W1567347505 cites W2004666146 @default.
• W1567347505 cites W2009188746 @default.
• W1567347505 cites W2017438314 @default.
• W1567347505 cites W2017784963 @default.
• W1567347505 cites W2020333924 @default.
• W1567347505 cites W2028844634 @default.
• W1567347505 cites W2045933247 @default.
• W1567347505 cites W2113423784 @default.
• W1567347505 cites W2113602915 @default.
• W1567347505 cites W2115807387 @default.
• W1567347505 cites W2119148360 @default.
• W1567347505 cites W2121890003 @default.
• W1567347505 cites W2123125411 @default.
• W1567347505 cites W2129696839 @default.
• W1567347505 cites W2138579842 @default.
• W1567347505 cites W2156555464 @default.
• W1567347505 cites W2159406891 @default.
• W1567347505 cites W2171967326 @default.
• W1567347505 doi "https://doi.org/10.1001/jamaneurol.2015.0853" @default.
• W1567347505 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4532561" @default.
• W1567347505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26052878" @default.
• W1567347505 hasPublicationYear "2015" @default.
• W1567347505 type Work @default.
• W1567347505 sameAs 1567347505 @default.
• W1567347505 citedByCount "38" @default.
• W1567347505 countsByYear W15673475052015 @default.
• W1567347505 countsByYear W15673475052016 @default.
• W1567347505 countsByYear W15673475052017 @default.
• W1567347505 countsByYear W15673475052018 @default.
• W1567347505 countsByYear W15673475052019 @default.
• W1567347505 countsByYear W15673475052020 @default.
• W1567347505 countsByYear W15673475052021 @default.
• W1567347505 countsByYear W15673475052022 @default.
• W1567347505 countsByYear W15673475052023 @default.
• W1567347505 crossrefType "journal-article" @default.
• W1567347505 hasAuthorship W1567347505A5012431384 @default.
• W1567347505 hasAuthorship W1567347505A5017751776 @default.
• W1567347505 hasAuthorship W1567347505A5020189594 @default.
• W1567347505 hasAuthorship W1567347505A5022478677 @default.
• W1567347505 hasAuthorship W1567347505A5052886370 @default.
• W1567347505 hasAuthorship W1567347505A5066335738 @default.
• W1567347505 hasBestOaLocation W15673475051 @default.
• W1567347505 hasConcept C104317684 @default.
• W1567347505 hasConcept C126322002 @default.
• W1567347505 hasConcept C134018914 @default.
• W1567347505 hasConcept C142724271 @default.
• W1567347505 hasConcept C16671776 @default.
• W1567347505 hasConcept C169760540 @default.
• W1567347505 hasConcept C170493617 @default.
• W1567347505 hasConcept C2777210258 @default.
• W1567347505 hasConcept C2777240379 @default.
• W1567347505 hasConcept C2778105408 @default.
• W1567347505 hasConcept C2780156709 @default.
• W1567347505 hasConcept C3020341438 @default.
• W1567347505 hasConcept C501734568 @default.
• W1567347505 hasConcept C54355233 @default.
• W1567347505 hasConcept C60644358 @default.
• W1567347505 hasConcept C71924100 @default.
• W1567347505 hasConcept C80161118 @default.
• W1567347505 hasConcept C86803240 @default.
• W1567347505 hasConceptScore W1567347505C104317684 @default.
• W1567347505 hasConceptScore W1567347505C126322002 @default.
• W1567347505 hasConceptScore W1567347505C134018914 @default.
• W1567347505 hasConceptScore W1567347505C142724271 @default.
• W1567347505 hasConceptScore W1567347505C16671776 @default.
• W1567347505 hasConceptScore W1567347505C169760540 @default.
• W1567347505 hasConceptScore W1567347505C170493617 @default.
• W1567347505 hasConceptScore W1567347505C2777210258 @default.
• W1567347505 hasConceptScore W1567347505C2777240379 @default.
• W1567347505 hasConceptScore W1567347505C2778105408 @default.
• W1567347505 hasConceptScore W1567347505C2780156709 @default.
• W1567347505 hasConceptScore W1567347505C3020341438 @default.
• W1567347505 hasConceptScore W1567347505C501734568 @default.
• W1567347505 hasConceptScore W1567347505C54355233 @default.
• W1567347505 hasConceptScore W1567347505C60644358 @default.
• W1567347505 hasConceptScore W1567347505C71924100 @default.
• W1567347505 hasConceptScore W1567347505C80161118 @default.
• W1567347505 hasConceptScore W1567347505C86803240 @default.
• W1567347505 hasIssue "8" @default.
• W1567347505 hasLocation W15673475051 @default.
• W1567347505 hasLocation W15673475052 @default.
• W1567347505 hasLocation W15673475053 @default.

• next